Quantitative real-time PCR with automated sample preparation for diagnosis and monitoring of cytomegalovirus infection in bone marrow transplant patientsKYEONG MAN HONG; NAJJAR, Hazim; HAWLEY, Mary et al.Clinical chemistry (Baltimore, Md.). 2004, Vol 50, Num 5, pp 846-856, issn 0009-9147, 11 p.Article

Real-time polymerase chain reaction with fluorescent hybridization probes for the detection of prevalent mutations causing common thrombophilic and iron overload phenotypesPARKS, Sharie B; POPOVICH, Bradley W; PRESS, Richard D et al.American journal of clinical pathology. 2001, Vol 115, Num 3, pp 439-447, issn 0002-9173Article

HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participantsBARTON, James C; LAFRENIERE, Susie A; LEIENDECKER-FOSTER, Catherine et al.American journal of hematology. 2009, Vol 84, Num 11, pp 710-714, issn 0361-8609, 5 p.Article

An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCRMÜLLER, Martin C; SAGLIO, Giuseppe; STOCKINGER, Hubertus et al.Haematologica (Roma). 2007, Vol 92, Num 7, pp 970-973, issn 0390-6078, 4 p.Article

Linked linear amplification : A new method for the amplification of DNAREYES, Antonio A; UGOZZOLI, Luis A; LOWERY, Jimmie D et al.Clinical chemistry (Baltimore, Md.). 2001, Vol 47, Num 1, pp 31-40, issn 0009-9147Article

TNFα facilitates clonal expansion of JAK2^V617F positive cells in myeloproliferative neoplasmsFLEISCHMAN, Angela G; AICHBERGER, Karl J; LORIAUX, Marc M et al.Blood. 2011, Vol 118, Num 24, pp 6392-6398, issn 0006-4971, 7 p.Article

BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinibSHERBENOU, Daniel W; HANTSCHEL, Oliver; SUPERTI-FURGA, Giulio et al.Blood. 2010, Vol 116, Num 17, pp 3278-3285, issn 0006-4971, 8 p.Article

A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-lnduced complete cytogenetic responsePRESS, Richard D; GALDERISI, Chad; RUI YANG et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 6136-6143, issn 1078-0432, 8 p.Article

Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders : Diagnostic issues in thrombophiliaPRESS, Richard D; BAUER, Kenneth A; KUJOVICH, Jody L et al.Archives of pathology & laboratory medicine (1976). 2002, Vol 126, Num 11, pp 1304-1318, issn 0363-0153, 15 p.Conference Paper

The BCR-ABL^35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemiaO'HARE, Thomas; ZABRISKIE, Matthew S; TOPLIN, Julie et al.Blood. 2011, Vol 118, Num 19, pp 5250-5254, issn 0006-4971, 5 p.Article

Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinibPRESS, Richard D; WILLIS, Stephanie G; LAUDADIO, Jennifer et al.Blood. 2009, Vol 114, Num 13, pp 2598-2605, issn 0006-4971, 8 p.Article

Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS Study initial screeningBARTON, James C; ACTON, Ronald T; GORDEUK, Victor R et al.American journal of hematology. 2008, Vol 83, Num 2, pp 126-132, issn 0361-8609, 7 p.Article

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trialsBRANFORD, Susan; FLETCHER, Linda; WANG, Y. Lynn et al.Blood. 2008, Vol 112, Num 8, pp 3330-3338, issn 0006-4971, 9 p.Article

BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CMLPRESS, Richard D; LOVE, Zac; TRONNES, Ashlie A et al.Blood. 2006, Vol 107, Num 11, pp 4250-4256, issn 0006-4971, 7 p.Article